About
CDMO, AAV manufacturing
Areas of Focus
Categories
Contract ManufacturingContract ManufacturingVirus TechnologyContract ManufacturingContract ResearchContract ManufacturingContract ManufacturingBoston & New England
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
7
As Collaborator
6
Total Enrollment
1,057
By Phase
PHASE2: 8PHASE1: 2PHASE1/PHASE2: 2PHASE3: 1
By Status
COMPLETED: 9TERMINATED: 3ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT01556841Collaborator
The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer
PHASE2Completed
94 participants
Started: Nov 30, 2013 · Completed: Apr 19, 2019
NCT01678872Lead Sponsor
A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
PHASE1Active, not recruiting
18 participants
Started: Aug 31, 2012 · Completed: Mar 31, 2029
NCT01856439Collaborator
Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease
PHASE1/PHASE2Terminated
15 participants
Started: May 31, 2011 · Completed: Apr 30, 2022
NCT01301443Lead Sponsor
Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
PHASE1Completed
21 participants
Started: Feb 28, 2011 · Completed: May 31, 2015
NCT01194960Lead Sponsor
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
PHASE2Terminated
25 participants
Started: Aug 31, 2010 · Completed: Mar 31, 2013
Locations (1)
Headquarters
Bedford, MA, United States
Map
Loading map...